Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.
Antiretroviral therapy (ART) reduces levels of HIV-1 and immune activation but both can persist despite clinically effective ART. The relationships among pre-ART and on-ART levels of HIV-1 and activation are incompletely understood, in part because prior studies have been small or cross-sectional. T...
Main Authors: | Rajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, Christina M Lalama, Joshua C Cyktor, Bernard J Macatangay, Charles R Rinaldo, Sharon A Riddler, Evelyn Hogg, Catherine Godfrey, Ann C Collier, Joseph J Eron, John W Mellors, ACTG A5321 Team |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-04-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1006285 |
Similar Items
-
Intact proviral DNA levels decline in people with HIV on antiretroviral therapy
by: J. Cyktor, et al.
Published: (2019-12-01) -
Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy
by: Melissa A. Tosiano, et al.
Published: (2022-12-01) -
HIV antibody and T cell responses on ART are associated with HIV DNA but not RNA
by: S.M. Keating, et al.
Published: (2017-12-01) -
PP 7.8 – 00060 Slowing or Reversal of Decay of Intact Proviruses Over Two Decades of Suppressive ART
by: J. Cyktor, et al.
Published: (2022-12-01) -
Dynamics of HIV-specific T cells on long-term ART differ by antigen recognised and by sex
by: Eva M. Stevenson, et al.
Published: (2019-12-01)